Decressac 1..15
نویسندگان
چکیده
, 163ra156 (2012); 4 Sci Transl Med et al. Mickael Decressac in Nigral Dopamine Neurons Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling − -Synuclein α Editor's Summary -synuclein toxicity and highlight Nurr1 as a promising new target for neuroprotective therapy. α against -synuclein toxicity. These results suggest that Nurr1 is a key player in the cellular defense α neurons subjected to induced expression of Nurr1, Ret receptor expression was restored as well as the response to GDNF in the dopamine complete failure of dopamine neurons to respond to exogenously applied GDNF. However, when the investigators downstream target, the GDNF receptor Ret. Deletion of Nurr1 resulted in reduced Ret expression, accompanied by a evidence that blockade of GDNF signaling is caused by reduced expression of the transcription factor Nurr1 and its -synuclein effectively block the trophic response of dopamine neurons to GDNF. They provide α concentrations of now show that excess cellular et al. mediated PD, Decressac − -synuclein α -synuclein toxicity. Using a rat model of α disease, GDNF has failed to afford protection in PD rodent models in which dopamine neurons are killed by this neuroprotection in patients with Parkinson disease (PD). Although effective in classic neurotoxin animal models of derived neurotrophic factor (GDNF) and its close relative neurturin are currently in clinical trials for − Glial cell line NURRishing Dopamine Neurons with GDNF
منابع مشابه
Neuropeptide Y and its role in CNS disease and repair.
Neuropeptide Y (NPY) is widely expressed throughout the CNS and exerts a number of important physiological functions as well as playing a role in pathological conditions such as obesity, anxiety, epilepsy, chronic pain and neurodegenerative disorders. In this review, we highlight some of the recent advances in our understanding of NPY biology and how this may help explain not only its role in h...
متن کاملmTOR inhibition alleviates L-DOPA-induced dyskinesia in parkinsonian rats.
The development of dyskinesia upon chronic L-DOPA treatment is a major complication for the management of the motor symptoms in Parkinson's disease (PD) patients. Efforts are made to understand the underlying mechanisms and identify targets for the pharmacological alleviation of dyskinesia without affecting the therapeutic effect of L-DOPA. Previous studies have shown that the mTOR pathway is h...
متن کاملARF6-dependent interaction of the TWIK1 K+ channel with EFA6, a GDP/GTP exchange factor for ARF6.
TWIK1 belongs to a family of K(+) channels involved in neuronal excitability and cell volume regulation. Its tissue distribution suggests a role in epithelial potassium transport. Here we show that TWIK1 is expressed in a subapical compartment in renal proximal tubules and in polarized MDCK cells. In nonpolarized cells, this compartment corresponds to pericentriolar recycling endosomes. We iden...
متن کاملExogenous neuropeptide Y promotes in vivo hippocampal neurogenesis.
Adult neurogenesis mainly occurs in two brain regions, the subventricular zone and the dentate gyrus (DG) of the hippocampus. Neuropeptide Y (NPY) is widely expressed throughout the brain and is known to enhance in vitro hippocampal cell proliferation. Mice lacking either NPY or the Y1 receptor display lower levels of cell proliferation, thereby suggesting a role for NPY in basal in vivo neurog...
متن کاملTFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity.
The aggregation of α-synuclein plays a major role in Parkinson disease (PD) pathogenesis. Recent evidence suggests that defects in the autophagy-mediated clearance of α-synuclein contribute to the progressive loss of nigral dopamine neurons. Using an in vivo model of α-synuclein toxicity, we show that the PD-like neurodegenerative changes induced by excess cellular levels of α-synuclein in nigr...
متن کامل